Delivery Order SPE2DB22D2103-SPE2DB24FR9SA

Award Date 7/22/24
Potential Completion Date 7/23/24
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $19,504.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract covers the procurement of the pharmaceutical product MULTAQ 400 MG TABLET 60S, which falls under...
This federal contract award, valued at $3,094.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of MULTAQ 400 MG TABLET 60S, a medical product. The contract has an ultimate completion date of January 10, 2024 and is a firm fixed-price agreement. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, valued at $31,137.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to support military healthcare programs. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $8,614.27, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, and has an ultimate completion date of January 28, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $22,238.61, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of MULTAQ 400 MG TABLET 60S, a prescription medication. The contract has a firm fixed price and a completion date of June 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $62,531.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a period of performance through July 11, 2024. The contract is a firm fixed price Delivery Order, which is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,994.53 delivery order contract is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract is a Firm Fixed Price (FFP) agreement with an ultimate completion date of October 23, 2024. This delivery order is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $6,673.62, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with an ultimate completion date of December 9, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is a part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $4,398.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a medical product, with a period of performance ending on January 13, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $23,208.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which is a delivery order under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, covers the procurement of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of September 26, 2023 and does not...
  • SPE2DB22D2103
    Indefinite Delivery Contract
  • SPE2DB22D2103-SPE2DB24FR9SA
    Delivery Order

This federal contract award, valued at $23,813.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a medical product, with a period of performance through July 23, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary contracting vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. AmerisourceBergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 5/17/25, 9:58 AM